CoChat

An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice

Open access

The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index; 10 of the 19 sources its claims cite were checked for support.

Abstract

Uncontrolled macrophage activation is now considered to be a critical event in the pathogenesis of chronic inflammatory diseases such as atherosclerosis, multiple sclerosis, and chronic venous leg ulcers. However, it is still unclear which environmental cues induce persistent activation of macrophages in vivo and how macrophage-derived effector molecules maintain chronic inflammation and affect resident fibroblasts essential for tissue homeostasis and repair. We used a complementary approach studying human subjects with chronic venous leg ulcers, a model disease for macrophage-driven chronic inflammation, while establishing a mouse model closely reflecting its pathogenesis. Here, we have shown that iron overloading of macrophages--as was found to occur in human chronic venous leg ulcers and the mouse model--induced a macrophage population in situ with an unrestrained proinflammatory M1 activation state. Via enhanced TNF-α and hydroxyl radical release, this macrophage population perpetuated inflammation and induced a p16(INK4a)-dependent senescence program in resident fibroblasts, eventually leading to impaired wound healing. This study provides insight into the role of what we believe to be a previously undescribed iron-induced macrophage population in vivo. Targeting this population may hold promise for the development of novel therapies for chronic inflammatory diseases such as chronic venous leg ulcers.

Overview

CoChat Summary

TL;DR

In human chronic venous leg ulcers and a mouse iron-overload model, iron loading induced an unrestrained proinflammatory M1 macrophage population coexpressing CD163 that persisted and impaired wound healing. These macrophages released TNFα and hydroxyl/peroxynitrite radicals, causing fibroblast p16INK4a-dependent senescence; iron chelation, macrophage depletion, or etanercept rescued healing in mice.

Key findings

  • In CVU biopsies, CD68+ macrophages represented up to 80% of cells in wound margins and persistently expressed M1 markers iNOS and TNFα in all studied CVU biopsies (patients 1–5), whereas acute wounds showed only a transient increase at day 2 and reduction by day 5. Iron deposits were found in macrophages and extracellular space in all studied CVU samples (patients 1–5 and 12–16) but were absent in acute wounds.
  • In iron-dextran-treated mice, iron accumulated in F4/80+ wound macrophages; these cells showed a persistent proinflammatory M1 profile (TNFα hi, IL-12 hi, CCR2 hi, Ly6C hi) with intermediate M2 markers at day 5. Iron-loaded mice had delayed wound healing at days 3, 5, 7, and 10, and desferrioxamine prevented iron loading and rescued the healing defect.
  • TNFα was causal in the mouse model: etanercept injected at day 3 rescued impaired healing at days 5, 7, and 10; clodronate liposome macrophage depletion at day 4 improved healing and fully rescued delayed repair at day 10; recombinant TNFα delayed healing in control acute wounds.
  • CVUs showed prevailing O2−· and OH·, increased 8OHdG and 3-nitrotyrosine, and γH2AX and p16INK4a expression in ulcer-adjacent fibroblasts but not CD18+ leukocytes; DFX or clodronate prevented γH2AX induction in iron-loaded mice.

Methods

  • Human samples: 16 patients with nonhealing CVUs (CEAP C6) persisting >4 months; 5-mm biopsies from ulcer edge and healthy skin of the same leg; acute wounds in 5 healthy volunteers biopsied at days 1, 2, and 5. Analyses included immunohistochemistry, immunofluorescence, flow cytometry, dihydrorhodamine123 ROS detection, and Western blotting.
  • Mouse model: 8- to 12-week-old C57BL/6 mice received iron-dextran (5 mg i.p. every 3 days for 21 days) or PBS-dextran; selected groups received DFX (6 mg), etanercept (25 µg/wound at days 3–6), recombinant TNFα (5,000 U/wound at days 2–4), or clodronate/PBS liposomes (12.5 mg/wound at day 4). Four 6-mm full-thickness excisional wounds were made, and wound areas were quantified.
  • In vitro: human PBMC-derived macrophages were treated with IFNγ/LPS, dexamethasone/IL-4, or Fenton-mimicking conditions (10 µM Fe(III) chloride, 10 µM ascorbate, 50 µM H2O2). Statistics used mean ± SD, two-tailed Student’s t test or Mann-Whitney U test, with P < 0.05 considered significant.

Limitations

  • Stated: the studies do not discern whether the unrestrained proinflammatory M1 population represents a continuum of functional states within the M1/M2 framework, nor whether the phenotype arises from differentiation of initial tissue macrophages or polarization of a distinct recruited population that replaces original macrophages.
  • Stated: the effect of topically applied DFX on macrophages is not known, and it remains to be seen whether beneficial outcomes from topical corticosteroids reflect a switch to antiinflammatory macrophages; T cell involvement in the pro-oxidative ulcer environment also remains unresolved.
  • Evident from the text: human data are largely observational/correlative with small sample sizes (16 CVU patients; some analyses used 5 acute wounds or 5 normal-skin samples), while causal rescue evidence comes from the mouse model; no human trial targeting this macrophage population is reported.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1172/jci44490

Cites

95 of 95 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Image 1
From the PDF
Image 2
From the PDF
Image 3
From the PDF
Image 4
From the PDF
Image 5
From the PDF
Image 6
From the PDF

Verification

Claims the paper makes

6 Valid · 0 Not valid · 6 Not checked · 66 Own results and interpretations

43 more claims

Create a free account to see all 78 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 7
  • It may state two separate claims as one. 26
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

10 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Research works printed but not linked: 2

  1. Dow, 1999, Ostomy Wound Manage., 45, 23
  2. Leibovich, 1975, Am J Pathol., 78, 71

Cited by

See all 1,100

Metadata

Authors
Sindrilaru, A., Peters, T., Wieschalka, S., Baican, C., Baican, A., Peter, H., Hainzl, A., Schatz, S., Qi, Y., Schlecht, A., Weiss, J. M., Wlaschek, M., Sunderkötter, C., & Scharffetter-Kochanek, K.
Affiliations
  • Universität Ulm (DE)
  • University of Münster (DE)
Venue
Journal of Clinical Investigation
Published
2011-03-01
Volume
121
Issue
3
Pages
985-997
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2019583561
Cited by
1,100
References
92
Citations by year
2026: 50 · 2025: 61 · 2024: 95 · 2023: 80 · 2022: 77 · 2021: 87 · 2020: 76 · 2019: 87 · 2018: 85 · 2017: 90 · 2016: 75 · 2015: 60 · 2014: 64 · 2013: 49 · 2012: 39
FWCI
56.78
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Baden-Württemberg Stiftung
  • European Commission (223236)
  • Deutsche Forschungsgemeinschaft (SU 195/3-1, KFO 142, SFB 497)
  • Universität Ulm
Topics
  • Health Sciences › Medicine › Surgery › Wound Healing and Treatments
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Health Sciences › Medicine › Surgery › Diagnosis and Treatment of Venous Diseases
Keywords
M1 macrophages, chronic venous leg ulcers, wound healing, chronic inflammation, fibroblast senescence, p16INK4a, TNF-α, hydroxyl radicals, macrophage activation, tissue repair
MeSH terms
Animals, Fibroblasts, Humans, Inflammation, Iron, Macrophages, Models, Biological, Phenotype, Tumor Necrosis Factor-alpha, Wound Healing, Cellular Senescence, Reactive Oxygen Species, Hydroxyl Radical, Cyclin-Dependent Kinase Inhibitor p16, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.